Richard Scott Struthers - 14 May 2025 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
/s/ Tobin Schilke, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
14 May 2025
Net transactions value
$0
Form type
4
Filing time
16 May 2025, 16:30:25 UTC
Previous filing
04 Apr 2025
Next filing
30 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Struthers Richard Scott President & CEO, Director C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO /s/ Tobin Schilke, as attorney-in-fact 16 May 2025 0001746298

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Gift $0 -90,400 -22% $0.000000 320,017 14 May 2025 Direct F1
transaction CRNX Common Stock Gift $0 +90,400 +16% $0.000000 661,205 14 May 2025 By Family Trust 1 F1
holding CRNX Common Stock 110,000 14 May 2025 By Family Trust 2
holding CRNX Common Stock 110,000 14 May 2025 By Family Trust 3
holding CRNX Common Stock 100,000 14 May 2025 By Family Trust 4
holding CRNX Common Stock 1,000 14 May 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift made by the Reporting person for no consideration.